ClinicalTrials.gg
Sign In

Cerebral Infarction clinical trials

The registry lists 219 studies for Cerebral Infarction across more than 10 countries. 46 are recruiting or about to start. 125 of them are mainly about Cerebral Infarction (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-21. Counting its 2 narrower conditions too, such as Infarction, Middle Cerebral Artery: 289 studies, 69 open.

Get an email when these change. Save the Cerebral Infarction studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
104
Status unknown
41
Recruiting
27
Terminated
18
Not yet recruiting
17
Withdrawn
5

Phase

Phase 2
35
Phase 4
29
Phase 3
28
Phase 1
10
Early Phase 1
1

Where

China
58
United States
23
France
22
Korea, Republic of
19
Canada
10
Japan
9

Who runs them

University of British Columbia (5) · National Institute of Neurological Disorders and Stroke (NINDS) (4) · Bispebjerg Hospital (4) · Assistance Publique - Hôpitaux de Paris (3) · Beijing Tiantan Hospital (3) · Asan Medical Center (3) · ReNeuron Limited (3) · Versailles Hospital (3)

What is being tested here

Drugs under test in Cerebral Infarction studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Aspirin335
Tirofiban222
Lacteol202
Cilostazol128
Butylphthalide102
Pegcetacoplan101
Tocilizumab111
Apixaban101
Emoxypine succinate101
Colchicine111

Drug classes tested here Factor Xa inhibitors 1 open · P2Y12 inhibitors 1 open · Thrombolytics 5

Coming up

6phase 3 studies under way
8studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 8, phase 3 first

Who these studies take

Of the 27 Cerebral Infarction studies recruiting now, 19 (70%) set no upper age limit and 0 (0%) stop at 75 or younger. 2 (7%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (7%) take healthy volunteers.

Recruiting studies that take each age, of 27
AgeWomenMen
102 (7%)2 (7%)
1822 (81%)22 (81%)
3024 (89%)24 (89%)
4024 (89%)24 (89%)
5025 (93%)25 (93%)
6527 (100%)27 (100%)
7527 (100%)27 (100%)
8521 (78%)21 (78%)

Across all 219 studies, recruiting or not: 15% stop at 75 or younger and 7% at 65; 11% take children; 0% are for women only and 1% for men only; 10% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Cerebral Infarction studies take

Of 32 observational studies under Cerebral Infarction, half reached primary completion within 61 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase28 mo16–49 · 27 studies——
Observational61 mo14–167 · 32 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 219. Browse all 219 → or search them.